Home › Funds › Marshall Wace › SGMT
Marshall Wace position in SGMT
SAGIMET BIOSCIENCES INC · Health Care
Latest position (Q1 2026)966.25K sh
Reported value held$5.04M
Portfolio Weight0.01%
First reportedQ4 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 16.79K | $90.97K | New |
| Q1 2024 | 35.68K | $193.38K | Add |
| Q3 2024 | 263.54K | $730.01K | New |
| Q4 2024 | 203.78K | $917.02K | Reduce |
| Q1 2025 | 22.27K | $72.58K | Reduce |
| Q4 2025 | 780.45K | $4.62M | New |
| Q1 2026 | 966.25K | $5.04M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SGMT
- BlackRock Inc 6.58M sh · $50.83M · Q2 2026
- Balyasny Asset Management 3.63M sh · $28.03M · Q2 2026
- Geode Capital Management 1.44M sh · $11.17M · Q2 2026
- Vanguard Group 1.26M sh · $7.46M · Q4 2025
- Millennium Management 937.02K sh · $7.24M · Q2 2026
- Goldman Sachs Group 759.09K sh · $5.87M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 724.80K sh · $5.60M · Q2 2026
- Northern Trust Corp 468.38K sh · $3.62M · Q2 2026
- Farallon Capital Management 415.00K sh · $3.21M · Q2 2026
- Renaissance Technologies 346.93K sh · $2.68M · Q2 2026
- UBS Group AG 339.93K sh · $2.63M · Q2 2026
- Citadel Advisors 289.93K sh · $2.24M · Q2 2026